litlas
ログインアカウント作成

Giulio Marchesini

1979–2024 年に発表

161
論文数
43,656
被引用数
98
h 指数
159
i10 指数

被引用数

Giulio Marchesini の年別被引用数1981 年: 被引用 1 件1982 年: 被引用 3 件1984 年: 被引用 1 件1985 年: 被引用 2 件1986 年: 被引用 1 件1987 年: 被引用 2 件1988 年: 被引用 1 件1989 年: 被引用 3 件1990 年: 被引用 4 件1991 年: 被引用 8 件1992 年: 被引用 9 件1993 年: 被引用 8 件1994 年: 被引用 10 件1995 年: 被引用 11 件1996 年: 被引用 6 件1997 年: 被引用 17 件1998 年: 被引用 13 件1999 年: 被引用 16 件2000 年: 被引用 26 件2001 年: 被引用 43 件2002 年: 被引用 119 件2003 年: 被引用 146 件2004 年: 被引用 257 件2005 年: 被引用 298 件2006 年: 被引用 323 件2007 年: 被引用 386 件2008 年: 被引用 417 件2009 年: 被引用 446 件2010 年: 被引用 451 件2011 年: 被引用 461 件2012 年: 被引用 418 件2013 年: 被引用 447 件2014 年: 被引用 460 件2015 年: 被引用 435 件2016 年: 被引用 423 件2017 年: 被引用 418 件2018 年: 被引用 360 件2019 年: 被引用 1,239 件2020 年: 被引用 1,504 件2021 年: 被引用 1,533 件2022 年: 被引用 1,223 件2023 年: 被引用 933 件2024 年: 被引用 1,468 件2025 年: 被引用 594 件2026 年: 被引用 22 件1983 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,375 件、この内訳の 19.7%中国: 引用元論文 1,766 件、この内訳の 10.3%イタリア: 引用元論文 1,535 件、この内訳の 9%イギリス: 引用元論文 1,079 件、この内訳の 6.3%ドイツ: 引用元論文 679 件、この内訳の 4%日本: 引用元論文 671 件、この内訳の 3.9%スペイン: 引用元論文 558 件、この内訳の 3.2%韓国: 引用元論文 520 件、この内訳の 3%オーストラリア: 引用元論文 508 件、この内訳の 3%フランス: 引用元論文 483 件、この内訳の 2.8%カナダ: 引用元論文 415 件、この内訳の 2.4%インド: 引用元論文 356 件、この内訳の 2.1%
0%19.7%その他 30.3%

機関

分野

  • Medicine85.4%
  • Biochemistry, Genetics and Molecular Biology7.4%
  • Psychology1.2%
  • Nursing1%
  • Neuroscience0.9%
  • Health Professions0.8%
  • その他3.3%

トピック

  • Liver Disease Diagnosis and Treatment22.9%
  • Liver Disease and Transplantation6.7%
  • Diet, Metabolism, and Disease5.9%
  • Diabetes, Cardiovascular Risks, and Lipoproteins4.2%
  • Alcohol Consumption and Health Effects3.4%
  • Diet and metabolism studies2.3%
  • その他54.6%

共著者

全論文

検索で開く
  1. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

    著者: Chris Estes, Quentin M. Anstee, M. Arias, Heike Bantel, Stefano Bellentani, Joan Caballería, Massimo Colombo, Antonio Craxı̀, Javier Crespo, Christopher P. Day, Yuichiro Eguchi, Andreas Geier, Loreta A. Kondili, Daniela C. Kroy, Jeffrey V. Lazarus, Rohit Loomba, Michael P. Manns, Giulio Marchesini, Atsushi Nakajima, Francesco Negro, Salvatore Petta, Vlad Ratziu, Manuel Romero‐Gómez, Arun J. Sanyal, Jörn M. Schattenberg, Frank Tacke, Junko Tanaka, Christian Trautwein, Lai Wei, Stefan Zeuzem, Homie Razavi - Journal of Hepatology 2018 被引用: 2,008

  2. The NAFLD fibrosis score

    著者: Paul Angulo, Jason M. Hui, Giulio Marchesini, Ellisabetta Bugianesi, Jacob George, Geoffrey C. Farrell, Felicity Enders, Sushma Saksena, Alastair D. Burt, John P. Bida, Keith D. Lindor, Schuyler O. Sanderson, Marco Lenzi, Leon A. Adams, James G. Kench, Terry M. Therneau, Christopher P. Day - Hepatology 2007 被引用: 3,200

  3. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

    著者: Tom H Karlsen, Nick Sheron, Shira Zelber-Sagi, Patrizia Carrieri, Geoffrey Dusheiko, Elisabetta Bugianesi, Rachel Pryke, Sharon J Hutchinson, Bruno Sangro, Natasha K Martin, Michele Cecchini, Mae Ashworth Dirac, Annalisa Belloni, Miquel Serra-Burriel, Cyriel Y Ponsioen, Brittney Sheena, Alienor Lerouge, Marion Devaux, Nick Scott, Margaret Hellard, Henkjan J Verkade, Ekkehard Sturm, Giulio Marchesini, Hannele Yki-Järvinen, Chris D Byrne, Giovanni Targher, Aviad Tur-Sinai, Damon Barrett, Michael Ninburg, Tatjana Reic, Alison Taylor, Tim Rhodes, Carla Treloar, Claus Petersen, Christoph Schramm, Robert Flisiak, Marieta Y Simonova, Albert Pares, Philip Johnson, Alessandro Cucchetti, Isabel Graupera, Christos Lionis, Elisa Pose, Núria Fabrellas, Ann T Ma, Juan M Mendive, Vincenzo Mazzaferro, Harry Rutter, Helena Cortez-Pinto, Deirdre Kelly, Robyn Burton, Jeffrey V Lazarus, Pere Ginès, Maria Buti, Philip N Newsome, Patrizia Burra, Michael P Manns - The Lancet 2021 被引用: 627

  4. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

    著者: Carel W. le Roux, Arne Astrup, Ken Fujioka, Frank L. Greenway, David Lau, Luc Van Gaal, Rafael Violante Ortíz, John Wilding, Trine Vang Skjøth, Linda Shapiro Manning, F. Xavier Pi‐Sunyer, A. Hamann, Alain Barakat, Matthias Blüher, Thomas Linn, Andrea Mölle, Alexander Segner, Petra Stübler, Regina Tosch-Sisting, Furio Pacini, Ferruccio Santini, Giulio Marchesini, Carlo Maria Rotella, Cecilia Invitti, Roberto Vettor, Silvio Buscemi, Pedro Mezquita Raya, Felipe Casanueva Freijoo, Ramón Gomis de Barbará, Raffaele Carraro, Enrique Romero Bobillo, Carmen de la Cuesta, Csaba Farsang, Albert Császár, Barbara Zahorska‐Markiewicz, Danuta Pupek-Musialik, Edward Franek, Lucyna Ostrowska, Magdalena Olszanecka‐Glinianowicz, Nebojša Lalić, Dragan Micić, Bernhard Ludvik, Bernhard Paulweber, Rudolf Prager, André Scheen, Luc Van Gaal, Arne Astrup, Kjeld Hermansen, Sten Madsbad, Aila Rissanen, Sakari Nieminen, Markku J. Savolainen, Michel Krempf, Monique Romon, M. Laville, Michel Marre, R Mira, Francis Finucane, Aletha Veenendaal, Frank van Berkum, Solrun Johannsson-Vidarsdóttir, V. Van de Walle, Eelco W. Meesters, Jøran Hjelmesæth, Tor Ole Klemsdal, Bård Kulseng, Birgit Bach-Kliegel, Kurt Laederach, Lukas Villiger, Alain Golay, Stefan Bilz, Thozhukat Sathyapalan, Stephen C. Bain, Sudhesh Kumar, Carel Wynard le Roux, Michael E. J. Lean, Barbara McGowan, Michael E.J. Lean, John Wilding, Gary Wittert, Ian Caterson, Joeseph Proietto, John Prins, Bruno Geloneze Neto, Jorge Luiz Gross, Antônio Roberto Chacra, Alfredo Halpern, Henrique Suplicy, Francis Chun Chung Chow, Hemant Thacker, Manoj Chadha, Hemaraj Chandalia, AG Unnikrishnan, Sanjay Kalra, Neeta Deshpande, Minakshi Shunmugavelu, Vaishali Deshmukh, Maximo Maislos, G. Lieberman, Ilan Shimon ほか 104 名 - The Lancet 2017 被引用: 844

  5. doi:https://doi.org/10.1016/j.jhep.2021.10.025

    著者: Jeffrey V. Lazarus, Henry E. Mark, Marcela Villota‐Rivas, Adam Palayew, Patrizia Carrieri, Massimo Colombo, Mattias Ekstedt, Gamal Esmat, Jacob George, Giulio Marchesini, Katja Novak, Ponsiano Ocama, Vlad Ratziu, Homie Razavi, Manuel Romero‐Gómez, Marcelo Silva, C Wendy Spearman, Frank Tacke, Emmanuel Tsochatzis, Yusuf Yılmaz, Zobair M. Younossi, Vincent Wai‐Sun Wong, Shira Zelber‐Sagi, Helena Cortez‐Pinto, Quentin M. Anstee - 2021 被引用: 261

  6. Non-alcoholic fatty liver disease: A patient guideline

    著者: Sven Francque, Giulio Marchesini, Achim Kautz, Martine Walmsley, Rebecca A. Dorner, Jeffrey V. Lazarus, Shira Zelber‐Sagi, Kate Hallsworth, Luca Busetto, Gema Frühbeck, Dror Dicker, Euan Woodward, Marko Korenjak, José Willemse, G.H. Koek, Shlomo Vinker, Mehmet Ungan, Juan Manuel Mendive, Christos Lionis - JHEP Reports 2021 被引用: 256

  7. openalex_id:w4200584065

    著者: Tom H. Karlsen, Nick Sheron, Shira Zelber‐Sagi, Patrizia Carrieri, Geoffrey Dusheiko, Elisabetta Bugianesi, Rachel Pryke, Sharon Hutchinson, Bruno Sangro, Natasha K. Martin, Michele Cecchini, Mae Dirac, Annalisa Belloni, Miquel Serra‐Burriel, Cyriel Y. Ponsioen, Brittney S Sheena, Aliénor Lerouge, Marion Devaux, Nick Scott, Margaret Hellard, Henkjan J. Verkade, Ekkehard Sturm, Giulio Marchesini, Hannele Yki‐Järvinen, Christopher D. Byrne, Giovanni Targher, Aviad Tur‐Sinai, Damon Barrett, Michael Ninburg, Tatjana Reić, Alison Taylor, Tim Rhodes, Carla Treloar, Claus Petersen, Christoph Schramm, Robert Flisiak, Marieta Simonova, Albert Parés, Philip J. Johnson, Alessandro Cucchetti, Isabel Graupera, Christos Lionis, Elisa Pose, Núria Fabrellas, Ann T., Juan Manuel Mendive, Vincenzo Mazzaferro, Harry Rutter, Helena Cortez‐Pinto, Déirdre Kelly, Robyn Burton, Jeffrey V. Lazarus, Pere Ginès, Marı́a Buti, Philip N. Newsome, Patrizia Burra, Michael P. Manns 被引用: 245

  8. Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database

    著者: Alessandro Vitale, Gianluca Svegliati‐Baroni, Alessio Ortolani, M. Cucco, Giulio Valentino Dalla Riva, Edoardo G. Giannini, Fabio Piscaglia, Gianludovico Rapaccini, Mariella Di Marco, Eugenio Caturelli, Marco Zoli, Rodolfo Sacco, Giuseppe Cabibbo, Fabio Marra, Andrea Mega, Filomena Morisco, Antonio Gasbarrini, Francesco Giuseppe Foschi, Gabriele Missale, Alberto Masotto, Gerardo Nardone, Giovanni Raimondo, Francesco Azzaroli, Gianpaolo Vidili, Filippo Oliveri, Filippo Pelizzaro, Rafael Morales, Umberto Cillo, Franco Trevisani, Luca Miele, Giulio Marchesini, Fabio Farinati - Gut 2021 被引用: 169

  9. Nonalcoholic Fatty Liver Disease

    著者: Giulio Marchesini, Mara Brizi, Giampaolo Bianchi, Sara Tomassetti, Elisabetta Bugianesi, Marco Lenzi, Arthur J. McCullough, Stefania Natale, Gabriele Forlani, Nazario Melchionda - Diabetes 2001 被引用: 2,582

  10. Association of nonalcoholic fatty liver disease with insulin resistance

    著者: Giulio Marchesini, Mara Brizi, Antonio Maria Morselli‐Labate, Giampaolo Bianchi, Elisabetta Bugianesi, Arthur J. McCullough, Gabriele Forlani, Nazario Melchionda - The American Journal of Medicine 1999 被引用: 1,578

  11. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

    著者: Zobair M. Younossi, Rohit Loomba, Quentin M. Anstee, Mary E. Rinella, Elisabetta Bugianesi, Giulio Marchesini, Brent A. Neuschwander‐Tetri, Lawrence Serfaty, Francesco Negro, Stephen H. Caldwell, Vlad Ratziu, Kathleen E. Corey, Scott L. Friedman, Manal F. Abdelmalek, Stephen A. Harrison, Arun J. Sanyal, Joel E. Lavine, Philippe Mathurin, Michael Charlton, Zachary Goodman, Naga P. Chalasani, Kris V. Kowdley, Jacob George, Keith D. Lindor - Hepatology 2017 被引用: 427

  12. Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation

    著者: Fei Chen, Saeed Esmaili, Geraint B. Rogers, Elisabetta Bugianesi, Salvatore Petta, Giulio Marchesini, Ali Bayoumi, Mayada Metwally, Mahmoud Karimi Azardaryany, Sally Coulter, Jocelyn M. Choo, Ramy Younes, Chiara Rosso, Christopher Liddle, Leon A. Adams, Antonio Craxı̀, Jacob George, Mohammed Eslam - Hepatology 2019 被引用: 322

  13. Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome

    著者: Giulio Marchesini, Elisabetta Bugianesi, Gabriele Forlani, Fernanda Cerrelli, Marco Lenzi, Rita Manini, Stefania Natale, Ester Vanni, Nicola Villanova, Nazario Melchionda, Mario Rizzetto - Hepatology 2003 被引用: 2,678

  14. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation

    著者: Zobair M. Younossi, Giulio Marchesini, Helena Pinto-Cortez, Salvatore Petta - Transplantation 2018 被引用: 400

  15. A position statement on NAFLD/NASH based on the EASL 2009 special conference

    著者: Vlad Ratziu, Stefano Bellentani, Helena Cortez‐Pinto, Chris Day, Giulio Marchesini - Journal of Hepatology 2010 被引用: 1,061

  16. Insulin Resistance: A Metabolic Pathway to Chronic Liver Disease *

    著者: Elisabetta Bugianesi, Arthur J. McCullough, Giulio Marchesini - Hepatology 2005 被引用: 890

  17. Insulin Resistance in Nonalcoholic Fatty Liver Disease

    著者: Elisabetta Bugianesi, Simona Moscatiello, Maria Francesca Ciaravella, Giulio Marchesini - Current Pharmaceutical Design 2010 被引用: 439

  18. The Effect of Lutein on Eye and Extra-Eye Health

    著者: Silvio Buscemi, Davide Corleo, Francesco Pace, Maria Letizia Petroni, Angela Satriano, Giulio Marchesini - Nutrients 2018 被引用: 250

  19. Management of non-alcoholic fatty liver disease

    著者: Maria Letizia Petroni, Lucia Brodosi, Elisabetta Bugianesi, Giulio Marchesini - BMJ 2021 被引用: 182

  20. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

    著者: Zobair M. Younossi, Rohit Loomba, Mary E. Rinella, Elisabetta Bugianesi, Giulio Marchesini, Brent A. Neuschwander‐Tetri, Lawrence Serfaty, Francesco Negro, Stephen H. Caldwell, Vlad Ratziu, Kathleen E. Corey, Scott L. Friedman, Manal F. Abdelmalek, Stephen A. Harrison, Arun J. Sanyal, Joel E. Lavine, Philippe Mathurin, Michael Charlton, Naga Chalasani, Quentin M. Anstee, Kris V. Kowdley, Jacob George, Zachary Goodman, Keith D. Lindor - Hepatology 2017 被引用: 361

  21. Branched-chain amino acids for people with hepatic encephalopathy

    著者: Lise Lotte Gluud, Gitte Dam, Íñigo Les, Giulio Marchesini, Mette Borre, Niels Kristian Aagaard, Hendrik Vilstrup - Cochrane Database of Systematic Reviews 2017 被引用: 287

  22. A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe

    著者: Jeffrey V. Lazarus, Mattias Ekstedt, Giulio Marchesini, Jillian Mullen, Katja Novak, Juan M. Pericàs, Elena Roel, Manuel Romero‐Gómez, Vlad Ratziu, Frank Tacke, Helena Cortez‐Pinto, Quentin M. Anstee - Journal of Hepatology 2019 被引用: 166

  23. Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease

    著者: Stefania Grimaudo, Rosaria Maria Pipitone, Grazia Pennisi, Ciro Celsa, Calogero Cammà, V. Di Marco, Maria Rosa Barcellona, Roberta Boemi, Marco Enea, Aurora Giannetti, Federica Spatola, Giulio Marchesini, Antonio Craxı̀, Salvatore Petta - Clinical Gastroenterology and Hepatology 2019 被引用: 152

  24. Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice

    著者: Giulio Marchesini, Salvatore Petta, Riccardo Dalle Grave - Hepatology 2015 被引用: 290